Modifications of a calcium phosphate cement with biomolecules-Influence on nanostructure, material, and biological properties

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 3 A, 2010, Pages 912-923

  Vater, Corina ^a   Lode, Anja ^a   Bernhardt, Anne ^a   Reinstorf, Antje ^b   Nies, Berthold ^b   Gelinsky, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b InnoTERE GmbH   (Germany)

Author keywords

Amino acids; Biocement D; Bone marrow stromal cells; Cocarboxylase; Osteoblasts

Indexed keywords

ASPARTIC ACIDS; BIOCEMENT D; BIOLOGICAL PERFORMANCE; BIOLOGICAL PROPERTIES; BONE MARROW STROMAL CELLS; BONE REGENERATION; BONE TISSUE; CALCIUM PHOSPHATE CEMENT; COCARBOXYLASE; GLUCOSE 1-PHOSPHATE; GLUCURONIC ACIDS; GROWTH FACTOR; HUMAN BONE MARROW; HUMAN OSTEOBLAST CELLS; HYDROXYAPATITE CRYSTALS; HYDROXYAPATITE PARTICLES; L -ASPARTIC ACIDS; L-ARGININE; L-LYSINE; OSTEOCONDUCTIVITY; OSTEOGENIC DIFFERENTIATION; SETTING REACTIONS; TARTARIC ACIDS;

ADHESION; APATITE; BIOCOMPATIBILITY; BIOMOLECULES; BONE; BONE CEMENT; CALCIUM PHOSPHATE; CELL CULTURE; CEMENTS; FUNCTIONAL GROUPS; GLUCOSE; HYDROXYAPATITE; NANOSTRUCTURES; ORGANIC ACIDS; OSTEOBLASTS; STEM CELLS;

AMINO ACIDS;

ARGININE; ASPARTIC ACID; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CEMENT; CEMENT; COCARBOXYLASE; GLUCOSE 1 PHOSPHATE; GLUCURONIC ACID; HYDROXYAPATITE; LYSINE; NANOMATERIAL; TARTARIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BIOCHEMICAL COMPOSITION; BIOCOMPATIBILITY; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL ANALYSIS; COMPRESSIVE STRENGTH; FLOW KINETICS; MESENCHYMAL STEM CELL; OSTEOBLAST;

ARGININE; ASPARTIC ACID; BIOCOMPATIBLE MATERIALS; BONE CEMENTS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HUMANS; MATERIALS TESTING; MESENCHYMAL STEM CELLS; MOLECULAR STRUCTURE; NANOSTRUCTURES; OSTEOBLASTS; THIAMINE PYROPHOSPHATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78249248007     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32920     Document Type: Article

References (53)

1. Driessens FCM, Boltong MG, Bermudez O, Planell JA,. Formulation and setting time of some calcium orthophosphate cements: A pilot study. J Mater Sci Mater Med 1993; 4: 503 -508.
2. Kenny SM, Buggy M,. Bone cements and fillers: A review. J Mater Sci Mater Med 2003; 14: 923 -938.
3. Dorozhkin SV,. Calcium orthophosphate cements and concretes. Materials 2009; 2: 221 -291.
4. Driessens FCM, Planell JA, Boltong MG, Khairoun I, Ginebra MP,. Osteotransductive bone cements. Proc Instn Mech Eng 1998; 212: 427 -453.
5. Linhart W, Briem D, Schmitz ND, Priemel M, Lehmann W, Rueger JM,. Treatment of metaphyseal bone defects after fractures of the distal radius. Medium-term results using a calcium-phosphate cement (BIOBON). Unfallchirurg 2003; 106: 618 -624.
6. Spies CKG, Schnürer S, Gotterbarm T, Breusch S,. The efficacy of Biobon™ and Ostim™ within metaphyseal defects using the Göttinger Minipig. Arch Orthop Trauma Surg 2009; 129: 979 -988.
7. Bostrom MP, Saleh KJ, Einhorn TA,. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 1999; 30: 647 -658.
8. Einhorn TA, Majeska RJ, Mohaideen A, Kagel EM, Bouxsein ML, Turek TJ, Wozney JM,. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 2003; 85-A: 1425 -1435.
9. Hempel U, Reinstorf A, Poppe M, Fischer U, Gelinsky M, Pompe W, Wenzel KW,. Proliferation and differentiation of osteoblasts on biocement D modified with collagen type I and citric acid. J Biomed Mater Res B Appl Biomater 2004; 71: 130 -143.
10. Reinstorf A, Ruhnow M, Gelinsky M, Pompe W, Hempel U, Wenzel KW, Simon P,. Phosphoserine-A convenient compound for modification of calcium phosphate bone cement collagen composites. J Mater Sci Mater Med 2004; 15: 451 -455.
11. Reinstorf A, Hempel U, Olgemöller F, Domaschke H, Schneiders W, Mai R, Stadlinger B, Rösen-Wolff A, Rammelt S, Gelinsky M, Pompe W,. O-phospho-L -serine modified calcium phosphate cements-Material properties, in vitro and in vivo investigations. Materialwiss Werkstofftech 2006; 37: 491 -503.
12. Lode A, Reinstorf A, Bernhardt A, Wolf-Brandstetter C, König U, Gelinsky M,. Heparin modification of calcium phosphate bone cements for VEGF functionalization. J Biomed Mater Res A 2008; 86A: 749 -759.
13. Knepper-Nicolai B, Reinstorf A, Hofinger I, Flade K, Wenz R, Pompe W,. Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D. Biomol Eng 2002; 19: 227 -231.
14. Rammelt S, Neumann M, Hanisch U, Reinstorf A, Pompe W, Zwipp H, Biewener A,. Osteocalcin enhances bone remodeling around hydroxyapatite/collagen composites. J Biomed Mater Res A 2005; 73: 284 -294.
15. Mai R, Lux R, Proff P, Lauer G, Pradel W, Leonhardt H, Reinstorf A, Gelinsky M, Jung R, Eckelt U, Gedrange T, Stadlinger B,. O-phospho-L -serine: A modulator of bone healing in calcium-phosphate cements. Biomed Tech 2008; 53: 229 -233.
16. Khairoun I, Boltong MG, Driessens FC, Planell JA,. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 1997; 38: 356 -360.
17. Caplan AL,. Mesenchymal stem cells. J Orthop Res 1991; 9: 641 -650.
18. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143 -147.
19. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH,. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279 -4295.
20. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM,. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41 -49.
21. Baksh D, Song L, Tuan RS,. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004; 8: 301 -316.
22. Bruder SP, Jaiswal N, Haynesworth SE,. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278 -294.
23. Philips AM,. Overview of the fracture healing cascade. Injury 2005; 36S: S5 -S7.
24. Bielby R, Jones E, McGonagle D,. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 2007; 38 (Suppl 1): 26 -32.
25. Marie PJ, Debiais F, Ha E,. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2, and BMP-2 signaling. Histol Histopathol 2002; 17: 877 -885.
26. Toriumi DM, Kotler HS, Luxenberg DH, Holtrop ME, Wang EA,. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991; 117: 1101 -1112.
27. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA,. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). Radiographic, histological, and biomechanical study in rats. J Bone Joint Surg (Am) 1992; 74: 659 -670.
28. Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH, Wang E,. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993; 293: 317 -326.
29. Geiger M, Li RH, Friess W,. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003; 55: 1613 -1629.
30. Khan SN, Lane JM,. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opin Biol Ther 2004; 4: 741 -748.
31. Ferrara N, Davis-Smyth T,. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4 -25.
32. Hausman MR, Schaffler MB, Majeska RJ,. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001; 29: 560 -564.
33. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM,. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000; 151: 879 -889.
34. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D,. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336 -3343.
35. Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K, Kumegawa M, Hakeda Y,. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 2000; 473: 161 -164.
36. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE,. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002; 30: 472 -477.
37. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE,. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 2005; 334: 561 -568.
38. Midy V, Plouet J,. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994; 199: 380 -386.
39. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H,. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: Autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 2005; 95: 827 -839.
40. Fernandez E, Boltong MG, Ginebra MP, Driessens FCM, Bermudez O, Planell J,. Development of a method to measure the period of swelling of calcium phosphate cements. J Mater Sci Lett 1996; 15: 1004 -1005.
41. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A,. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 2006; 27: 4428 -4433.
42. Sato K, Kumagai Y, Tanaka J,. Apatite formation on organic monolayers in simulated body enviroment. J Biomed Mater Res 2000; 50: 16 -20.
43. Gbureck U, Rösch P, Thull R,. Influence of amino acids on the physical and chemical properties of calcium phosphate cements. BIOmaterialien 2006; 7: 271 -277.
44. Koutsopoulos S, Dalas E,. The crystallization of hydroxyapatite in the presence of lysine. J Colloid Interface Sci 2000; 231: 207 -212.
45. Jack KS, Vizcarra G, Trau M,. Characterization and surface properties of amino-acid-modified carbonate-containing hydroxyapatite particles. Langmuir 2007; 23: 12233 -12242.
46. Kilpadi KL, Pi-Ling C, Bellis SL,. Hydroxyapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res 2001; 57: 258 -267.
47. Sawyer AA, Hennessy KM, Bellis SL,. The effect of adsorbed serum proteins. RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials 2007; 28: 383 -392.
48. Sogo Y, Ito A, Matsuno T, Oyane A, Tamazawa G, Satoh T, Yamazaki A, Uchimura E, Ohno T,. Fibronectin-calcium phosphate composite layer on hydroxyapatite to enhance adhesion, cell spread and osteogenic differentiation of human mesenchymal stem cells in vitro. Biomed Mater 2007; 2: 116 -123.
49. Schönmeyr BH, Wong AK, Li S, Gewalli F, Cordiero PG, Mehrara BJ,. Treatment of hydroxyapatite scaffolds with fibronectin and fetal calf serum increases osteoblast adhesion and proliferation in vitro. Plast Reconstr Surg 2008; 121: 751 -762.
50. Maekawa K, Yoshida Y, Mine A, Fujisawa T, van Meerbeek B, Suzuki K, Kuboki T,. Chemical interaction of polyphosphoric acid with titanium and its effect on human bone marrow derived mesenchymal stem cell behavior. J Biomed Mater Res A 2007; 82: 195 -200.
51. Klee D, Mosena F, Furlani D, Wambach M, Lösel R, Ma N,. Arginine containing nanofibres for stimulated angiogenesis of tissue engineered substrates. BIOmaterialien 2008; 9: 143.
52. Salasznyk RM, Williams WA, Boskey A, Batorsky A, Plopper GE,. Adhesion to vitronectin and collagen i promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 2004; 1: 24 -34.
53. Boix T, Gómez-Morales J, Torrent-Burgués J, Monfort A, Puigdoménech P, Rodríguez-Clemente R,. Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem 2005; 99: 1043 -1050.